• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常成年人及不同类型高血压患者的血清血管紧张素转换酶活性

Serum angiotensin converting enzyme activity in normal adults and patients with different types of hypertension.

作者信息

Dux S, Aron N, Boner G, Carmel A, Yaron A, Rosenfeld J B

出版信息

Isr J Med Sci. 1984 Dec;20(12):1138-42.

PMID:6097566
Abstract

The serum converting enzyme activity (SCEA) was measured in 86 healthy individuals (1.44 +/- 0.82 u, mean +/- SD), 39 patients with essential hypertension (1.53 +/- 0.71 u), 7 patients with hypertension due to renal artery stenosis (1.76 +/- 0.77 u), 14 patients with chronic renal failure (2.10 +/- 0.57 u), 7 patients with renal failure and hypertension (2.62 +/- 0.35 u), 22 normotensive pregnant women (1.02 +/- 0.26 u) and 6 hypertensive pregnant women (1.1 +/- 0.3). No difference was detected between men and women or between normotensives and hypertensives. However, a significant rise in SCEA was found in patients with chromic renal failure (P less than 0.005), in whom an enlarged pulmonary vascular bed and accelerated cellular breakdown are thought to be the causes of the elevated SCEA. During pregnancy, subnormal SCEA was found (P less than 0.005), and this is thought to be due to the enzyme consumption in the kinin system, which is activated during pregnancy. We assume that converting enzyme is not a limiting factor in angiotensin conversion, and most probably it does not contribute significantly to the pathogenesis of hypertension.

摘要

对86名健康个体(血清转换酶活性[SCEA]为1.44±0.82单位,均值±标准差)、39名原发性高血压患者(1.53±0.71单位)、7名肾动脉狭窄所致高血压患者(1.76±0.77单位)、14名慢性肾衰竭患者(2.10±0.57单位)、7名肾衰竭合并高血压患者(2.62±0.35单位)、22名血压正常的孕妇(1.02±0.26单位)以及6名高血压孕妇(1.1±0.3单位)进行了血清转换酶活性测定。未检测到男性与女性之间或血压正常者与高血压患者之间存在差异。然而,慢性肾衰竭患者的SCEA显著升高(P<0.005),据认为其肺血管床扩大和细胞分解加速是SCEA升高的原因。在孕期,发现SCEA低于正常水平(P<0.005),据认为这是由于孕期激活的激肽系统消耗了该酶所致。我们假定转换酶不是血管紧张素转换的限制因素,而且很可能它对高血压的发病机制贡献不大。

相似文献

1
Serum angiotensin converting enzyme activity in normal adults and patients with different types of hypertension.正常成年人及不同类型高血压患者的血清血管紧张素转换酶活性
Isr J Med Sci. 1984 Dec;20(12):1138-42.
2
Serum angiotensin-converting enzyme levels in patients with chronic renal failure.
Pathol Biol (Paris). 1983 Mar;31(3):182-5.
3
Angiotensin-converting enzyme activity in renal disorders: influence of disease pattern, hemodialysis and transplantation.
Clin Nephrol. 1984 Mar;21(3):178-83.
4
[Serum angiotensin converting enzyme activity in patients with chronic renal insufficiency].[慢性肾功能不全患者的血清血管紧张素转换酶活性]
Med Arh. 1987;41(4):155-8.
5
Low prekallikrein and high angiotensin-converting enzyme activity in patients with chronic renal failure on haemodialysis.
Nephrol Dial Transplant. 1991;6 Suppl 3:6-9.
6
[The correlation between serum angiotensin I-converting enzyme activity and the renin-angiotensin-aldosterone system in hypertensive patients (author's transl)].高血压患者血清血管紧张素I转换酶活性与肾素-血管紧张素-醛固酮系统之间的相关性(作者译)
Nihon Naibunpi Gakkai Zasshi. 1981 Aug 20;57(8):1118-26. doi: 10.1507/endocrine1927.57.8_1118.
7
[Activity of serum angiotensin converting enzyme in pregnancy-induced hypertension].妊娠高血压综合征患者血清血管紧张素转换酶活性研究
Zhonghua Fu Chan Ke Za Zhi. 1991 Jan;26(1):9-11, 60.
8
Effect of captopril on serum angiotensin converting enzyme and blood pressure in hypertensive patients.卡托普利对高血压患者血清血管紧张素转换酶及血压的影响。
J Assoc Physicians India. 1996 Feb;44(2):109-11.
9
Renovascular hypertension. New diagnostic and therapeutic procedures.肾血管性高血压。新的诊断和治疗方法。
Scand J Urol Nephrol Suppl. 1995;170:1-78.
10
Neutral endopeptidase and angiotensin I converting enzyme insertion/deletion gene polymorphism in humans.人类中性内肽酶和血管紧张素I转换酶插入/缺失基因多态性
J Hum Hypertens. 2004 Feb;18(2):119-25. doi: 10.1038/sj.jhh.1001646.

引用本文的文献

1
Angiotensin-converting enzyme in innate and adaptive immunity.先天免疫和适应性免疫中的血管紧张素转换酶。
Nat Rev Nephrol. 2018 May;14(5):325-336. doi: 10.1038/nrneph.2018.15. Epub 2018 Mar 26.
2
A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.现代对血管紧张素转换酶传统和非传统生物学功能的理解。
Pharmacol Rev. 2012 Dec 20;65(1):1-46. doi: 10.1124/pr.112.006809. Print 2013 Jan.
3
Conformational changes of blood ACE in chronic uremia.慢性尿毒症患者血液 ACE 的构象变化。
PLoS One. 2012;7(11):e49290. doi: 10.1371/journal.pone.0049290. Epub 2012 Nov 16.
4
The acute effects of exercise and glucose ingestion on circulating angiotensin-converting enzyme in humans.运动和摄入葡萄糖对人体循环血管紧张素转换酶的急性影响。
Eur J Appl Physiol. 2004 Aug;92(4-5):579-83. doi: 10.1007/s00421-004-1078-5.
5
Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction.血管紧张素转换酶基因缺失等位基因与冠状动脉粥样硬化和心肌梗死独立且密切相关。
Br Heart J. 1995 Dec;74(6):584-91. doi: 10.1136/hrt.74.6.584.
6
Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study.血浆血管紧张素转换酶水平的家族相似性:南希研究
Am J Hum Genet. 1988 Nov;43(5):774-80.
7
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.来自综合分离分析和连锁分析的证据表明,血管紧张素I转换酶(ACE)基因的一个变体控制血浆ACE水平。
Am J Hum Genet. 1992 Jul;51(1):197-205.